XML 97 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Accrued Liabilities, Current [Abstract]    
Preclinical and clinical trial accruals $ 57,780 $ 56,283
API and bulk drug product price true-up 75,055 0
Acquired in-process research and development asset 0 35,000
Payroll and related accruals 22,562 20,909
Accrued co-promotion expenses - current 36,677 25,746
Contract liabilities to pharmaceutical distributors 390 3,176
Roxadustat profit share to AstraZeneca 7,280 7,895
Property taxes and other taxes 7,691 12,610
Professional services 5,480 6,074
Other 6,858 4,906
Total accrued and other current liabilities $ 219,773 $ 172,599